Results of a phase 1 study to evaluate safety and pharmacokinetics of anti-zika virus immune globulin (Human) (Zikv-ig) in healthy volunteers

Authors
Category Primary study
JournalAmerican Journal of Tropical Medicine and Hygiene
Year 2020
This article has no abstract
Epistemonikos ID: 10acc4c3d4e4135ec4912f4b38b885727e30219f
First added on: Feb 13, 2025